|
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study |
|
|
|
Title: |
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study |
Author: |
Cheng, Ying He, Yong Li, Wei Zhang, He-long Zhou, Qing Wang, Buhai Liu, Chunling Walding, Andrew Saggese, Matilde Huang, Xiangning Fan, Minhao Wang, Jia Ramalingam, Suresh S. |
Appeared in: |
Targeted oncology |
Paging: |
Volume 16 () nr. 2 pages 165-176 |
Year: |
2021-02-05 |
Contents: |
|
Publisher: |
Springer International Publishing, Cham |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|